Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Buy Us a Coffee
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2022-45454
Vulnerability Information
Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
Sensitive information disclosure due to insecure folder permissions. The following products are affected: Acronis Agent (Windows) before build 30161, Acronis Cyber Protect 15 (Windows) before build 30984.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
信息暴露
Source: NVD (National Vulnerability Database)
Vulnerability Title
Acronis Agent 安全漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Acronis Agent是新加坡安克诺斯（Acronis）公司的一个代理软件。 Acronis Agent (Windows) 30161之前版本、Acronis Cyber Protect 15 (Windows) 30984之前版本存在安全漏洞，该漏洞源于文件夹权限设置不当。攻击者利用该漏洞泄露敏感信息。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
AcronisAcronis Agent 0 ~ 30161 -
AcronisAcronis Cyber Protect 15 0 ~ 30984 -
II. Public POCs for CVE-2022-45454
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2022-45454
Please Login to view more intelligence information
IV. Related Vulnerabilities
Same product: Acronis Agent
Same vendor: Acronis
Same weakness: CWE-200
V. Comments for CVE-2022-45454

No comments yet

Leave a comment